Advertisement

Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 600x60px
Document › Details

University of Mainz (Johannes-Gutenberg-Universität, JGU). (10/24/16). "Press Release: Scientists in Mainz Develop a Novel Method to Benchmark and Improve the Performance of Protein Measurement Techniques. Quantum Leap in the Reliability of Mass Spectrom

Organisation Organisation University of Mainz, University Medical Center (Universitätsmedizin Mainz)
  Group University of Mainz (Johannes Gutenberg University)
Products Product LFQbench software
  Product 2 mass spectrometry-based proteomic research test
Persons Person Tenzer, Stefan (Univ Mainz 201312 Prof at Institute for Immunology at Univ Medical Center)
  Person 2 Schild, Hansjörg (Univ Mainz 201312 Prof + Director of Institute for Immunology at Univ Medical Center)
     


Modern mass spectrometry systems enable scientists to routinely determine the quantitative composition of cells or tissue samples. However, different analysis software packages often produce different results from the same raw data. An international team of researchers led by Professor Stefan Tenzer from the Mainz University Medical Center has now addressed this problem. In the framework of an international collaboration with leading laboratories worldwide, the team has compared and modified various analysis software packages to ensure that the different software solutions produce consistent results. A wide range of laboratories around the world are benefiting from this work, which enables researchers to analyze or compare the results of quantitative proteomics assays in a standardized way. This is crucial to detect certain organic diseases, such as cancer, at an early stage. The results of Tenzer and his team have now been published in the highly respected academic journal, Nature Biotechnology.

When doctors want to find the cause of a particular illness, they have to take samples of cells or bodily fluids. These samples are then analyzed by modern Omics techniques which enable to reproducibly quantify thousands of proteins across large numbers of samples to identify novel biomarkers for diseases. The analysis of these highly complex datasets critically depends on specialized software packages. Unfortunately, different software packages sometimes deliver divergent results from the same raw data, thus complicating the analysis.

This is exactly the problem that Professor Stefan Tenzer and his team from the Institute of Immunology at the University Medical Center of Johannes Gutenberg University Mainz (JGU) set out to resolve. "We wanted to find a way of optimally comparing samples, even when different analysis software sometimes produces deviating results," explained Tenzer. For his latest project he used two defined samples with precisely defined ratios of constituents. The bioinformatics specialists in Tenzer's team, Dr. Pedro Navarro and Dr. Jörg Kuharev, developed a specialist piece of software, termed LFQbench. This allowed the team to study the differences between the various analysis programs in detail. "Using LFQbench, we were able to show that the results delivered by the various programs differed significantly," explained Navarro. "This finding alone has significant impact for the scientific community. But we have taken the project a step further: Our close collaboration with the developers of the individual programs enabled them to modify and improve their analysis packages so that they now produce highly convergent results," added Tenzer. This broadens the scope of applications of the mass spectrometry technique known as quantitative proteomics. A proteome is the entirety of proteins expressed by a cell. "This means that in the future, mass spectrometry will be able to provide even more benefits both in basic research and as a potential diagnostic tool," Tenzer pointed out.

"This development represents a breakthrough for mass spectrometry-based quantitative proteomics and makes this method increasingly important as a standard procedure for use in the diagnosis of various disorders, such as cancer or allergies," emphasized the Chief Scientific Officer of the Mainz University Medical Center, Professor Ulrich Förstermann. "I am particularly proud that our researchers are delivering applied research with such significant impact."

The pioneering results were achieved under the aegis of the technology platform "Mass Spectrometry and Quantitative Proteomics" based at the Research Center for Immunotherapy (FZI) at Johannes Gutenberg University Mainz (JGU). "This success demonstrates the necessity of combining different areas of expertise in technology platforms at the University Medical Center. Without central support, it is nowadays almost impossible to accomplish achievements of this kind," said Professor Hansjörg Schild, Director of the Institute of Immunology and coordinator of the FZI for many years.

Over recent years, Professor Stefan Tenzer and his team in Mainz have developed several improvements to the techniques used for mass spectrometry-based quantitative proteomics. These methods reproducibly detect and quantify thousands of proteins in samples of cells, tissues, or bodily fluids, and enable researchers to identify proteins that are differentially expressed. "The years of work within the technology platform, especially in international joint projects, have paid off in terms of this quantum leap forward in mass spectrometry-based quantitative proteomics," concluded Tenzer.


Publication
P. Navarro et al., A multicenter study benchmarks software tools for label-free proteome quantification, Nature Biotechnology, 3 October 2016,
DOI:10.1038/nbt.3685


Contact

Mainz University Medical Center
Professor Dr. Stefan Tenzer
Institute of Immunology
Langenbeckstr. 1
55131 Mainz
Tel +49 6131 17-6199
Fax +49 6131 17-6202
E-Mail: tenzer@uni-mainz.de
Homepage: http://www.immunologie.uni-mainz.de/neu/en/mitarbeiter-info/Stefan-Tenzer/34


Read more
press release "Immunologists of the Mainz University Medical Center present improved mass spectrometric method for proteomic analyses" (17 March 2014)


   
Record changed: 2016-12-23

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for University of Mainz (Johannes Gutenberg University)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px